John Schreiber, MD


Undergraduate - Franklin & Marshall College (2001)
Medical School - University of Maryland School of Medicine (2006)
Residency - Children's National Medical Center (2011)
Fellowship - National Institutes of Health (2013)
Schreiber J, Chapman KA, Summar ML, Mew NA, Sutton VR, Macleod E, Stagni K, Ueda K, Franks J, Island E, Matern D, Peña L, Smith B, Urv T, Venditt C, Chakarapani A, Gropman AL. Neurologic considerations in propionic acidemia. Mol Gen Metab 2011; 105(1): 10-15.
Schreiber JM, Zelleke T, Gaillard WD, Kaulas H, Dean N, Carpenter JL. Continuous video EEG for patients with acute encephalopathy in a pediatric intensive care unit. Neurocrit Care 2012; 17(1): 31-38.
Pierson TM, Yuan H, Marsh ED, Fuentes-Fajardo K, Adams DR, Markello T, Golas G, Simeonov DR, Holloman C, Tankovic A, Karamchandani MM, Schreiber JM, Mullikin JC; PhD for the NISC Comparative Sequencing Program, Tifft CJ, Toro C, Boerkoel CF, Traynelis SF, Gahl WA. GRIN2A mutation and early-onset epileptic encephalopathy: personalized therapy with memantine. Ann Clin Transl Neurol 2014; 1: 190-198.
Schreiber JM, Lanham DC, Trescher WH, Sparks SE, Wassif CA, Caffo BS, Porter FD, Tierney E, Gropman AL, Ewen JB. Variations in EEG discharges predict ADHD severity within individual Smith-Lemli-Opitz patients. Neurology 2014; 83: 151-159.
Pearl P, Schreiber J, Theodore W, McCarter R, Barrios E, Yu J, Wiggs E, He J, Gibson M. Taurine trial in succinic semialdehyde sehydrogenase (SSADH) deficiency and elevated CNS GABA. Neurology 2014; 82: 940-944.
3 - Children